Search Results - "Grossniklaus, Hans"

Refine Results
  1. 1
  2. 2

    Retinoblastoma. Fifty Years of Progress. The LXXI Edward Jackson Memorial Lecture by Grossniklaus, Hans E

    Published in American journal of ophthalmology (01-11-2014)
    “…Purpose To review the progress made in understanding the genetic basis, molecular pathology, and treatment of retinoblastoma since the previous Jackson lecture…”
    Get full text
    Journal Article
  3. 3

    Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle by Jung, Jae Hwan, Chiang, Bryce, Grossniklaus, Hans E., Prausnitz, Mark R.

    Published in Journal of controlled release (10-05-2018)
    “…Treatment of many posterior-segment ocular indications would benefit from improved targeting of drug delivery to the back of the eye. Here, we propose the use…”
    Get full text
    Journal Article
  4. 4

    Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture by Grossniklaus, Hans E

    Published in JAMA ophthalmology (01-04-2013)
    “…To the best of my knowledge, this study demonstrates for the first time small, apparently dormant micrometastasis in the liver of patients with uveal melanoma…”
    Get more information
    Journal Article
  5. 5

    Age-related retinopathy in NRF2-deficient mice by Zhao, Zhenyang, Chen, Yan, Wang, Jian, Sternberg, Paul, Freeman, Michael L, Grossniklaus, Hans E, Cai, Jiyang

    Published in PloS one (29-04-2011)
    “…Cumulative oxidative damage is implicated in the pathogenesis of age-related macular degeneration (AMD). Nuclear factor erythroid 2-related factor 2 (NRF2) is…”
    Get full text
    Journal Article
  6. 6

    Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis by Szalai, Eszter, Wells, Jill R., Ward, Laura, Grossniklaus, Hans E.

    Published in Ophthalmology (Rochester, Minn.) (01-02-2018)
    “…To examine the BRCA1-associated protein-1 (BAP1) expression of primary uveal melanomas without and with metastasis, and to analyze the correlation between the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Metastatic uveal melanoma: The final frontier by Rantala, Elina S., Hernberg, Micaela M., Piperno-Neumann, Sophie, Grossniklaus, Hans E., Kivelä, Tero T.

    Published in Progress in retinal and eye research (01-09-2022)
    “…Treatment of primary intraocular uveal melanoma has developed considerably, its driver genes are largely unraveled, and the ways to assess its risk for…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Animal models of choroidal and retinal neovascularization by Grossniklaus, Hans E., Kang, Shin J., Berglin, Lennart

    Published in Progress in retinal and eye research (01-11-2010)
    “…There have been numerous types of animal models of choroidal neovascularization (CNV) and retinal neovascularization (RNV). Understanding the pathobiology of…”
    Get full text
    Journal Article
  11. 11

    Uveal melanoma by Jager, Martine J., Shields, Carol L., Cebulla, Colleen M., Abdel-Rahman, Mohamed H., Grossniklaus, Hans E., Stern, Marc-Henri, Carvajal, Richard D., Belfort, Rubens N., Jia, Renbing, Shields, Jerry A., Damato, Bertil E.

    Published in Nature reviews. Disease primers (09-04-2020)
    “…Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. UMs are usually initiated by a mutation in GNAQ or GNA11 , unlike cutaneous…”
    Get full text
    Journal Article
  12. 12

    Overrepresentation of human epidermal growth factor receptor 2 positive- and Luminal B breast cancer metastases in the eyes and orbit by Stålhammar, Gustav, Grossniklaus, Hans E.

    Published in Eye (London) (01-08-2023)
    “…Background Breast cancer is the most common cancer to spread to the choroid and orbit. Depending on a set of prognostic and predictive biomarkers, breast…”
    Get full text
    Journal Article
  13. 13

    Therapeutic Options for Retinoblastoma by Mendoza, Pia R, Grossniklaus, Hans E

    Published in Cancer control (01-04-2016)
    “…Retinoblastoma is the most common primary intraocular malignancy in children. The management of retinoblastoma is complex and depends on several factors. This…”
    Get more information
    Journal Article
  14. 14

    Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma by Dong, Lei, You, Shuo, Zhang, Qing, Osuka, Satoru, Devi, Narra S, Kaluz, Stefan, Ferguson, Jalisa H, Yang, Hua, Chen, Guoliang, Wang, Binghe, Grossniklaus, Hans E, Van Meir, Erwin G

    Published in Clinical cancer research (01-04-2019)
    “…Uveal melanoma (UM) is the most prevalent and lethal intraocular malignancy in adults. Here, we examined the importance of hypoxia in UM growth and tested the…”
    Get full text
    Journal Article
  15. 15

    Estimation of the timing of BAP1 mutation in uveal melanoma progression by Uner, Ogul E., See, Thonnie Rose O., Szalai, Eszter, Grossniklaus, Hans E., Stålhammar, Gustav

    Published in Scientific reports (26-04-2021)
    “…Uveal melanoma is the most common primary intraocular malignancy. A vast majority of metastasizing tumors have mutations in the BAP1 gene. Here, we investigate…”
    Get full text
    Journal Article
  16. 16

    The Biology of Retinoblastoma by Mendoza, Pia R, Grossniklaus, Hans E

    “…Retinoblastoma, the most common primary intraocular cancer of childhood, is a malignancy arising in the developing retina. Tumor formation usually begins with…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Spontaneous Corneal Clearing after Descemet's Stripping without Endothelial Replacement by Shah, Rupa D., MD, Randleman, J. Bradley, MD, Grossniklaus, Hans E., MD, MBA

    Published in Ophthalmology (Rochester, Minn.) (01-02-2012)
    “…Purpose To report spontaneous corneal clearing with improved visual acuity and central endothelial cell repopulation after Descemet's stripping without…”
    Get full text
    Journal Article
  19. 19
  20. 20